2 weeks Ago By ABMN Staff
Rhumbline Advisers lifted its stake in Semler Scientific, Inc. ( NASDAQ:SMLR – Free Report ) by 27.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission.
The institutional investor owned 6,197 shares of the company’s stock after acquiring an additional 1,320 shares during the period. Rhumbline Advisers owned 0.09% of Semler Scientific worth $213,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. CWM LLC lifted its holdings in Semler Scientific by 486.3% in the second quarter.
CWM LLC now owns 897 shares of the company’s stock valued at $31,000 after acquiring an additional 744 shares during the period. BOKF NA purchased a new stake in shares of Semler Scientific in the 1st quarter valued at approximately $227,000. Horizon Investment Services LLC grew its holdings in shares of Semler Scientific by 35.
8% during the 1st quarter. Horizon Investment Services LLC now owns 8,352 shares of the company’s stock worth $244,000 after purchasing an additional 2,203 shares during the period. Truvestments Capital LLC purchased a new position in shares of Semler Scientific during the 1st quarter worth approximately $263,000.
Finally, Financial Strategies Group Inc. purchased a new position in shares of Semler Scientific during the second quarter worth $263,000. Hedge funds and other institutional investors own 49.
37% of the company’s stock. Semler Scientific Stock Up 1.1 % NASDAQ:SMLR opened at $23.
77 on Friday. The company has a market cap of $167.96 million, a price-to-earnings ratio of 8.
52 and a beta of 0.96. The company has a fifty day simple moving average of $27.
47 and a two-hundred day simple moving average of $28.94. Semler Scientific, Inc.
has a 52 week low of $20.88 and a 52 week high of $53.38.
Insider Buying and Selling In related news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total transaction of $283,500.
00. Following the sale, the chief executive officer now owns 60,220 shares in the company, valued at $1,707,237. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink .
Insiders own 13.00% of the company’s stock. Semler Scientific Profile ( Free Report ) Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.
The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Recommended Stories Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter .
.
